CN103751475A - Composition for treating spleen-kidney deficiency lupus erythematosus - Google Patents
Composition for treating spleen-kidney deficiency lupus erythematosus Download PDFInfo
- Publication number
- CN103751475A CN103751475A CN201410005267.XA CN201410005267A CN103751475A CN 103751475 A CN103751475 A CN 103751475A CN 201410005267 A CN201410005267 A CN 201410005267A CN 103751475 A CN103751475 A CN 103751475A
- Authority
- CN
- China
- Prior art keywords
- parts
- lupus erythematosus
- composition
- spleen
- kidney deficiency
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a composition for treating spleen-kidney deficiency lupus erythematosus, and belongs to the field of traditional Chinese medicines. The composition comprises the following components in parts by weight: 12 to 18 parts of codonopsis pilosula, 25 to 35 parts of astragali radix, 12 to 18 parts of dioscorea opposite, 12 to 18 parts of salvia miltiorrhiza, 12 to 18 parts of caulis spatholobi, 12 to 18 parts of gentiana macrophylla, 10 to 15 parts of loranthus parasiticus, 10 to 15 parts of tortoise plastron, 10 to 15 parts of eucommia ulmoides, 8 to 12 parts of poria cocos, 8 to 12 parts of zaocys dhumnade, 8 to 12 parts of semen plantaginis, and 10 to 15 parts of buthus martensi kirsch. The composition for treating spleen-kidney deficiency lupus erythematosus is reasonable in combination, has the effects of tonifying kidney and spleen, and regulating Yin and Yang, shows a remarkable effect on treating systemic lupus erythematosus, has no any toxic and side effects, and creates cure rate higher than 80%.
Description
Technical field:
The present invention relates to tcm field, relate in particular to a kind of compositions for the treatment of spleen kidney both deficiency type lupus erythematosus.
Background technology:
Systemic lupus erythematosus (sle) (systemic lupus erythematosus, SLE) is a kind of autoimmune disease that involves multisystem, many organs and have multiple autoantibody to occur.Owing to having a large amount of pathogenic autoantibodys and immune complex to cause tissue injury in body.Can there is clinically the performance of each system and visceral organ injury, as skin, joint, serous coat, heart, kidney, central nervous system, blood system etc.This disease worldwide occurs, and prevalence is 4,/10 ten thousand～25,/10 ten thousand, and Asia and Black people's prevalence are higher, and the prevalence of China is 70,/10 ten thousand～75,/10 ten thousand.Women falls ill obviously more than male, is about 10: 1, and the women of child-bearing age are onset peak, and old man and child also can be ill.
Primary disease belongs to YIN YANG toxin syndrome, the YANG toxin syndrome of Chinese medicine and sends out the disease categories such as speckle, butterfly spot, solar dermatitis, chronic erythematosus, seborrheic dermatitis.The curative effect of medication for the treatment of lupus erythematosus is not good at present, and side effect is stronger, and cure rate is not high.
Summary of the invention:
The object of the present invention is to provide a kind of compositions for the treatment of spleen kidney both deficiency type lupus erythematosus, to solve the problems of the technologies described above.
Technical problem to be solved by this invention realizes by the following technical solutions:
A compositions for the treatment of spleen kidney both deficiency type lupus erythematosus, is characterized in that, comprises following component and group component:
The preferred group component of each component is:
Above pharmaceutical composition in use, according to the dialectical plus-minus medicine of the state of an illness: hyperpyrexia adds Cornu Bubali powder and takes after mixing it with water, lasting underground heat adds Cortex Lycii, Radix Stellariae, the Rhizoma Anemarrhenae, cardiac insufficiency adds Radix Ginseng, and anasarca adds Spora Lygodii, celestial being's head, and lumbago adds the Cortex Eucommiae, menoxenia adds Herba Leonuri leaf, Herba Lycopi, erythema obviously adds Flos Celosiae Cristatae, Flos Rosae Rugosae, Flos Campsis, and mental symptom adds Fel Serpentis, Pericarpium Citri Reticulatae end, and urine retention adds WUPI YIN.
This pharmaceutical composition adopts traditional approach decoction.
The invention has the beneficial effects as follows:
The compositions for the treatment of spleen kidney both deficiency type lupus erythematosus provided by the invention, compatibility is reasonable, has the effect of kidney and spleen invigorating, YIN and YANG balance regulating, remarkable to systemic lupus erythematosus effect, has no side effect, and cure rate can reach more than 80%.
The specific embodiment:
For technological means, creation characteristic that the present invention is realized, reach object and effect is easy to understand, below in conjunction with specific embodiment, further set forth the present invention.
Embodiment 1
Treat a compositions for spleen kidney both deficiency type lupus erythematosus, component is:
This pharmaceutical composition adopts Chinese medicine decocting method, gets its decoction liquor and takes.
Embodiment 2
Treat a compositions for spleen kidney both deficiency type lupus erythematosus, component is:
This pharmaceutical composition adopts Chinese medicine decocting method, gets its decoction liquor and takes.
Embodiment 3
Treat a compositions for spleen kidney both deficiency type lupus erythematosus, component is:
This pharmaceutical composition adopts Chinese medicine decocting method, gets its decoction liquor and takes.
More than show and described ultimate principle of the present invention, principal character and advantage of the present invention.The technical staff of the industry should understand; the present invention is not restricted to the described embodiments; what in above-described embodiment and description, describe is only preference of the present invention; be not used for limiting the present invention; without departing from the spirit and scope of the present invention; the present invention also has various changes and modifications, and these changes and improvements all fall in the claimed scope of the invention.The claimed scope of the present invention is defined by appending claims and equivalent thereof.
Claims (2)
1. a compositions for the treatment of spleen kidney both deficiency type lupus erythematosus, is characterized in that, comprises following component and group component:
2. the compositions for the treatment of spleen kidney both deficiency type lupus erythematosus according to claim 1, is characterized in that, the preferred group component of each component is:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410005267.XA CN103751475A (en) | 2014-01-03 | 2014-01-03 | Composition for treating spleen-kidney deficiency lupus erythematosus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410005267.XA CN103751475A (en) | 2014-01-03 | 2014-01-03 | Composition for treating spleen-kidney deficiency lupus erythematosus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103751475A true CN103751475A (en) | 2014-04-30 |
Family
ID=50518902
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410005267.XA Pending CN103751475A (en) | 2014-01-03 | 2014-01-03 | Composition for treating spleen-kidney deficiency lupus erythematosus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103751475A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104001129A (en) * | 2014-05-22 | 2014-08-27 | 陈洪佳 | Lupus pill for treating systemic lupus erythematosus |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101670039A (en) * | 2009-10-16 | 2010-03-17 | 周大红 | Traditional Chinese medicine for curing lupus erythematosis and preparation method thereof |
-
2014
- 2014-01-03 CN CN201410005267.XA patent/CN103751475A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101670039A (en) * | 2009-10-16 | 2010-03-17 | 周大红 | Traditional Chinese medicine for curing lupus erythematosis and preparation method thereof |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104001129A (en) * | 2014-05-22 | 2014-08-27 | 陈洪佳 | Lupus pill for treating systemic lupus erythematosus |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103272188A (en) | Agent for curing sequelae of apoplexy | |
| CN101134085A (en) | Traditional Chinese medicine for treating apoplexy and hemiplegia | |
| CN101385815A (en) | Traditional Chinese medicine for treating dementia after stroke | |
| CN103768371A (en) | Traditional Chinese medicine formula for treating lobar pneumonia | |
| CN101129617A (en) | Traditional Chinese medicine for treating cirrhosis | |
| CN104027517A (en) | Traditional Chinese medicine for treating acute enteritis | |
| CN104906368A (en) | Traditional Chinese medicine composition for treating systemic lupus erythematosus | |
| CN103341133A (en) | Traditional Chinese medicine composition for treating fatty liver and preparation method thereof | |
| CN101167932A (en) | Traditional Chinese medicine for treating chronic hepatitis B | |
| CN103751475A (en) | Composition for treating spleen-kidney deficiency lupus erythematosus | |
| CN103768431A (en) | Composition for treating intense toxic heat type lupus erythematosus | |
| CN101757160A (en) | Itching-relieving soup | |
| CN101134077A (en) | Traditional Chinese medicine for treating aural vertigo | |
| CN101129695A (en) | Traditional Chinese medicine for treating liver depression headache | |
| CN103751557A (en) | Composition for treating toxic heat injury and yin qi type lupus erythematosus | |
| CN103372083A (en) | Chinese medicinal composition for treating spontaneous perspiration | |
| CN103071079B (en) | Traditional Chinese medicinal composition for treating prurigo nodularis | |
| CN105456887A (en) | Pharmaceutical for treating aplastic anemia | |
| CN104127602A (en) | Traditional Chinese medicine for treating fatty liver | |
| CN104998147A (en) | Traditional Chinese medicine composition for treating pulmonary tuberculosis | |
| CN103751348A (en) | Composition for treating meridian-collateral blockage type lupus erythematosus | |
| CN101130003A (en) | Traditional Chinese medicine for treating acute cholecystitis | |
| CN101143182A (en) | Traditional Chinese medicine for treating alcoholic cirrhosis | |
| CN105311460A (en) | Traditional Chinese medicine for treating vascular neuralgia headache | |
| CN103316283A (en) | Traditional Chinese medicinal composition for treating chronic cholecystitis, and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140430 |